Search Results - "Baddeley, E."

The Application of CRISPR/Cas Systems for Antiviral Therapy by Baddeley, Helen J. E., Isalan, Mark

“…As CRISPR/Cas systems have been refined over time, there has been an effort to apply them to real world problems, such as developing sequence-targeted…”
Get full text

The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons by Machiela, Emily, Jeloka, Ritika, Caron, Nicholas S., Mehta, Shagun, Schmidt, Mandi E., Baddeley, Helen J. E., Tom, Colton M., Polturi, Nalini, Xie, Yuanyun, Mattis, Virginia B., Hayden, Michael R., Southwell, Amber L.

“…Huntington disease (HD) is a fatal, inherited neurodegenerative disorder caused by a mutation in huntingtin (HTT). While mutant HTT is present ubiquitously…”
Get full text

Antithrombotic therapy decision making in advanced cancer: Patients and clinicians' views, perspectives, and experiences by Baddeley, E, Sivell, S, Edwards, M, Lifford, K, Arfuch, V, Font, C, Mahe, I, Coma-Auli, N, Soegaard, M, Enggaard, H, Klok, F A, Noble, S, Hojen, A A

“…Abstract Background Decision-making regarding antithrombotic therapy (ATT) for patients with advanced cancer is highly challenging, given the competing risks…”
Get full text

PO-48 The risks of chemotherapy induced cancer associated thrombosis: what do patients know and what do they need to know? by Baddeley, E., Pease, N., Nelson, A., Sulman, J., Crabtree, A., Noble, S.

Get full text

PO-04 The impact of a patient information video on patient awareness and understanding of chemotherapy induced cancer associated thrombosis by Baddeley, E., Pease, N., Nelson, A., Sulma, J., Crabtree, A., Noble, S.

Get full text

P09.08.B UNDERSTANDING THE HOLISTIC NEEDS OF PEOPLE LIVING WITH GLIOMA AND THEIR CAREGIVERS: A THEMATIC ANALYSIS OF THE SEMI-STRUCTURED INTERVIEWS FOR THE COBRA STUDY by Baddeley, E, Sivell, S, Retzer, A, Nelson, A, Bulbeck, H, Seddon, K, Grant, R, Adams, R, Watts, C, Aiyegbusi, O, Kearns, P, Rivera, S, Dirven, L, Calvert, M, Byrne, A

“…Abstract BACKGROUND The needs of people with brain tumours are unique, particularly in terms of neurocognitive impacts, and their subsequent effects on primary…”
Get full text

P09.03.A DEVELOPMENT OF A CORE OUTCOME SET FOR USE IN ADULT PRIMARY GLIOMA PHASE III INTERVENTIONAL TRIALS - A MIXED METHODS STUDY by Retzer, A, Baddeley, E, Sivell, S, Nelson, A, Bulbeck, H, Seddon, K, Grant, R, Adams, R, Watts, C, Aiyegbusi, O, Kearns, P, Cruz Rivera, S, Dirven, L, Calvert, M, Byrne, A

“…Abstract BACKGROUND Glioma patients’ high symptom burden and the poor prognosis of high grade glioma has emphasised quality of survival and overall…”
Get full text

P09.04.B The importance of treatment tolerability for people with glioma: registry review and qualitative findings from the COBra Study by Baddeley, E, Retzer, A, Sivell, S, Seddon, K, Bulbeck, H, Nelson, A, Adams, R, Grant, R, Watts, C, Aiyegbusi, O, Rivera, S, Kearns, P, Dirven, L, Calvert, M, Byrne, A

“…Abstract Background Gliomas are the commonest form of primary brain tumour, accounting for 80% of malignant brain tumours. Gliomas represent a heterogeneous…”
Get full text

Delivery of mutant huntingtin-lowering antisense oligonucleotides to the brain by intranasally administered apolipoprotein A-I nanodisks by Aly, Amirah E.-E., Caron, Nicholas S., Black, Hailey Findlay, Schmidt, Mandi E., Anderson, Christine, Ko, Seunghyun, Baddeley, Helen J.E., Anderson, Lisa, Casal, Lorenzo L., Rahavi, Reza S.M., Martin, Dale D.O., Hayden, Michael R.

“…Lowering mutant huntingtin (mHTT) in the central nervous system (CNS) using antisense oligonucleotides (ASOs) is a promising approach currently being evaluated…”
Get full text

The Highway Rights Of The Public by BADDELEY, E

Get full text

Friendly Societies and the Medical Profession by Baddeley, C. E.

Get full text

Concurrent Epidemic Measles And Diphtheria by Baddeley, C. E.

Get full text

To The Editor Of The Times by Baddeley, S. E. L

Get full text

Friendly Societies and the Medical Profession by Moxon, Alban H.

Get full text